What is it about?
Comparison of the efficacy and safety of bone marrow(BM)–derived mesenchymal stem cell(MSCs) and adipose-derived(AD) MSCs in the management of osteoarthritis of knee from randomized controlled trials(RCTs) available in the literature.
Featured Image
Photo by Jasmin Schreiber on Unsplash
Why is it important?
With the incline towards novel therapeutics methods, various source of MSC has been advocated to have superior effects than the other. Hence this meta-analysis resolves the issue between the two commonly used sources of MSC for OA Knee.
Perspectives
We bring insight into the role of selection of the source of MSC for Management of OA Knee with Stem Cell Therapy.
Dr Sathish Muthu
Government Hospital, Velayuthampalayam, Karur, TN, India.
Read the Original
This page is a summary of: Does the Source of Mesenchymal Stem Cell Have an Effect in the Management of Osteoarthritis of the Knee? Meta-Analysis of Randomized Controlled Trials, Cartilage, August 2020, SAGE Publications,
DOI: 10.1177/1947603520951623.
You can read the full text:
Contributors
The following have contributed to this page
